Rose Ann Boll, Ph.D.
Senior Research & Development Staff
Nuclear Medicine Program
Nuclear Science and Technology Division
Oak Ridge National Laboratory (ORNL)
RECENT RELEVANT REPRESENTATIVE PUBLICATIONS:
Boll, R. A.,
Malkemus, D. and Mirzadeh, S. “Production of
Actinium-225 for Alpha Particle-Mediated Radioimmunotherapy,” Appl.
Radiat. Isot., 62, 667-679 (2005).
Boll, R. A.,
Malkemus, D. W. and Mirzadeh, S. “Production
of Actinium-225 for Alpha Particle Mediated Radiotherapy,” For,
225th Annual Meeting, Amer. Chem. Soc., New Orleans, LA, March 23-27,
2003.
Boll, R. A.,
Malkemus, D. W. and Mirzadeh, S. “Production
of Actinium-225 for Alpha Particle Mediated Radiotherapy,” For, Annual
ANS Meeting, San Diego CA, June 1-5, 2003.
Craig, A. M.,
Marsh, D. J., Boll, R. A., Schweitzer, G. K. and Mirzadeh, S. “Recoil-Separation of 221Fr from 213Bi from 225Ac,” 225th
Annual Meeting, Amer. Chem. Soc., New Orleans, LA, March 23-27, 2003.
Davis, I. A., Glowienka, K.
A., Boll, R. A., Deal, K. A., Brechbiel, M. W., Stabin,
M., Bocksler,
P. N., Mirzadeh
S. and Kennel, S. J. "Comparison of 225Actinium
Chelates: Tissue Distribution and Radiotoxicity," Nucl. Med. Biol., 26, 581-589 (1999). Kennel, S. J. Boll, R., Stabin, M., Schuller, H. M. and Mirzadeh, S.
"Radioimmunotherapy of Micrometastases in Lung with Vascular Targeted 213Bi,"
Brit. J. Cancer, 80, 175-184 (1999).
Kennel, S. J., Lankford, P. K., Foote, L. J., Davis, I. A.,
Boll, R. A. and Mirzadeh, S. "Combination Vascular Targeted and Tumor Targeted
Radioimmunotherapy," Cancer Biotherapy and Radiopharmaceuticals, 14,
371-379 (1999).
Kennel, S. J., Stabin, M., Foote, L. J., Lankford, P. K..
Terzaghi-Howe, M., Patterson, H., Barkenbus, J., Popp, D. M., Boll, R. and Mirzadeh, S.
"Toxicity and Microdosimetry for 213Bi Bound to Membranes of Monolayer and
Speroid Cultures of Tumor Cells," Radiation Res., 151, 244-256 (1999).
Davis, I. A., Glowienka, K. A., Boll, R. A., Deal, R. A.,
Brechbiel, M. W., Stabin, M, Bochsler, P. N., Mirzadeh, S., Kennel, S. J.,
"Comparison of Actinium-225 Chelates: Tissue Distribution and Radiotoxicity", Journal
of Nuclear Medicine and Biology, 26, 581-589 (1999).
Kennel, S. J., Boll, R., Stabin, M., Schuller, H. M. and
Mirzadeh, S., "Radioimmunotherapy of Micrometastases in Lung with Vascular Targeted 213Bi",
British Journal of Cancer, 80, 175-184 (1999).
Webb, O. F., Boll, R. A., Lucero, A. J., DePaoli, D. W.,
"Purification of Thorium From Uranium-233 Process Residue,"
Separation Science and Technology, 34(6&7), 975-985 (1999).
Boll, R. A., Mirzadeh, S. and Kennel, S. J.,
"Optimization of Radiolabeling of Immunoproteins with 213Bi",
Proceedings of Symposium on Radiochemistry and Radioimmunotherapy, 212th ACS National
Meeting, Orlando, Fl, Aug. 24-28, 1996, Radiochimica Acta. 79, 145-179
(1997).
Boll, R. A., Mirzadeh, S., Kennel, S. J., Depaoli, D. W., and
Webb, O. F.,"The Ac-225/Bi-213 Biomedical Generator," American Nuclear Society
Winter Meeting, Albuquerque, NM, Nov. 16-20, 1997.
Boll, R. A., Schweitzer, G. K., Garber, R. W. "An
Improved Actinide Separation Method for Environmental Samples," Radioanalytical
and Nuclear Chemistry. 220(2), 201-206 (1997).
Schweitzer, G. K., and Boll, R. A., "Radioanalytical
Chemistry," International Technology, Knoxville, TN, 1994.
This site was updated 04/25/2005
Back to Publications page
|